High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer-Reference-Cited by-同舟云学术

High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer

Published:2018-01 Issue: Volume:17 Page:153303381880969
ISSN:1533-0346
Container-title:Technology in Cancer Research & Treatment
language:en
Short-container-title:Technol Cancer Res Treat

Author:

Yang Yi¹,Sun Peng²,Xu Wei²^ORCID,Xia Wei¹

Affiliation:

1. Department of Endocrinology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

2. Department of Urology, Shandong Provincial Hospital, Jinan, China

Publisher

SAGE Publications

Subject

Cancer Research,Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1533033818809694

Reference25 articles.

1. Livin, a Novel Inhibitor of Apoptosis Protein Family Member

2. Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy

3. Expression and prognostic significance of LIVIN, SURVIVINand other apoptosis-related genes in the progression of superficial bladder cancer

4. Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine

5. The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA-seq and ChIP-seq Identification of Unique and Overlapping Targets of GLI Transcription Factors in Melanoma Cell Lines;Cancers;2022-09-19

2. Livin/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma;Journal of Genetic Engineering and Biotechnology;2021-09-26

3. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma;Technology in Cancer Research & Treatment;2020-01-01